Imunon Inc. (NASDAQ: IMNN)
$1.41
-0.0050 ( -0.35% ) 11.7K
Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the body's immune system. It is a fully integrated, clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases.
Market Data
Open
$1.41
Previous close
$1.41
Volume
11.7K
Market cap
$13.44M
Day range
$1.41 - $1.43
52 week range
$0.48 - $2.00
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Jun 14, 2024 |
4 | Insider transactions | 1 | Jun 14, 2024 |
4 | Insider transactions | 1 | Jun 14, 2024 |
4 | Insider transactions | 1 | Jun 14, 2024 |
4 | Insider transactions | 1 | Jun 14, 2024 |
4 | Insider transactions | 1 | Jun 14, 2024 |
4 | Insider transactions | 1 | Jun 14, 2024 |
8-k | 8K-related | 13 | Jun 13, 2024 |
3 | Insider transactions | 1 | Jun 10, 2024 |
8-k | 8K-related | 15 | May 20, 2024 |